Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE

Last updated:

Abstract:

The present disclosure relates to pharmaceutical compositions of adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).

Status:
Application
Type:

Utility

Filling date:

24 Jul 2020

Issue date:

1 Sep 2022